Dong-A Socio Holdings will boost global competitiveness, CEO Kim said

Published: 2013-01-30 06:59:00

Updated: 2013-01-30 06:59:00

The establishment of Dong-A Socio Holdings will allow us to be more specialized in key growth industries and more aggressive in investing in them, Dong-A Pharmaceutical CEO Kim Won-bae said in a shareholders’ meeting on Monday.

Dong-A Pharm, No. 1 drug maker in the country, will be transformed...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK